NEW YORK – (DGIwire) – In today’s health-conscious society, many people are engaging in higher and higher levels of physical activity throughout their entire lives, via sports or rigorous exercise. While keeping themselves physically fit this way, they run the risk of exposing themselves to repeated injury. Athletes can take advantage of sports medicine treatments to get themselves back on their feet; but after a certain period of time and a certain number of injuries, a doctor might recommend hip replacement surgery.
According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases, doctors once reserved hip replacement surgery primarily for people over 60 years of age. In more recent years, however, doctors have found that hip replacement surgery can be very successful in younger people as well. New technologies have improved the artificial parts, allowing them to withstand more stress and strain and last longer.
Over time, sustained injuries can result in the need for surgery. Consider the hip joint, which can lead to early onset of arthritis from high-impact activities. This procedure removes the ball of the upper femur (thighbone) as well as damaged cartilage from the hip socket. The ball is replaced with a metal cup that is fixed to the socket. The implant is designed to create a new, smoothly functioning joint that prevents painful bone-on-bone contact.
One company with an innovative approach to this form of surgery is East Taunton, MA-based OMNIlife science, Inc., which is committed to designing, manufacturing and distributing high-quality orthopedic devices for hip and knee replacement surgeries. The company’s OMNI ARC™ Tissue Sparing Hip System gives surgeons and their patients a wide range of options without the disadvantages of metal-on-metal articulation.
The OMNI ARC™ implant conserves bone in the proximal femur, making it a good choice for younger, more active patients. Its design requires less bone to be removed during surgery, and its unique shape is conducive to any surgical approach, including minimally invasive approaches. OMNI’s own minimally invasive instrumentation can lower the size of the required incision from 6-8 inches to 3-4 inches, reducing the extent to which the surgeon must disrupt the soft tissue surrounding the hip. As a result, the patient’s muscles, ligaments and tendons experience less trauma during surgery.
OMNI has refined the use of tapered stems in their implants, including the OMNI ARC. A tapered stem wedges tightly near the top of the femur, reducing the potential for motion between the stem and the bone, which can cause pain. By providing precise sizing options, OMNI’s stems provide surgeons with the best chance of achieving optimal fit.
George B. Cipolletti, President and CEO of OMNIlife science, says, “With injuries on the rise among high-activity individuals, some are being faced with the option of hip replacement at ever-younger ages. The OMNI ARC™ is one of several new technologies affording patients and their doctors a more streamlined, more comfortable approach.”